400 Capital's $1.5B OceanFirst Deal Is the First US Mortgage SRT

I have watched capital-relief trades move from a European bank specialty to a global $30 billion-a-year market. This deal marks the moment a US non-bank asset manager, not a European bank syndicate desk, took the lead on structuring one for an American mortgage book. That is the story underneath the press release.

Why This Deal Matters More Than the Press Release Says

Every SRT press release says the same thing: cost-effective, non-dilutive, win-win. Skip that. Here is what is actually new.

First, 400 Capital Management issued this deal itself, as a fund manager, rather than buying into a bank-arranged syndication. Jeff Willoughby, the firm's Head of Residential Credit Strategy, told BusinessWire the firm expects the structure to "serve as a template for future issuance" and wants to help build a "vibrant" US SRT ecosystem. Read that as ambition, not description. A template only exists after somebody proves it works once. 400CM just tried to be that somebody.

Second, the timing is not an accident. According to American Banker's coverage of the deal, the structure gives US banks another capital-relief option while a US update to Basel is still pending. Federal banking agencies proposed a rewrite of the Basel III endgame rules in March 2026 that would cut mortgage risk weights across the board. Simpson Thacher's analysis of the March 19, 2026 proposal found the rules would let banks apply loan-to-value-based risk weights as low as 20% to 25% on well-collateralized mortgages, down from a flat 50% today, and estimated up to $643 billion in additional lending capacity for standardized-approach banks alone. KPMG's regulatory alert on the proposal frames the net effect as a real capital release for banks that qualify, not a rounding error. If that rule finalizes as proposed, the case for paying a third party to shed mortgage risk gets weaker. OceanFirst and 400CM built this deal in the window before that happens. Third, this is a residential mortgage SRT, not the corporate or consumer loan SRTs that dominate the market. Mortgage books have granular, long-duration, prepayment-sensitive cash flows that behave nothing like a middle-market loan book. Getting DBRS Morningstar comfortable enough to rate CLNs against that risk profile is a harder underwriting problem than it looks from the outside, and it is the part of this deal most likely to get copied or to blow up first.

What an SRT Actually Is, Mechanically

Strip away the acronym and an SRT is a bank buying insurance on a slice of its own loan book. The bank keeps the loans on its balance sheet, keeps the customer relationships, and keeps servicing the mortgages. What it sells off is the credit risk on a specific tranche of losses, usually the "mezzanine" layer that sits above where the bank's own equity absorbs first losses but below the safest, senior-most exposure.

The mechanics run through two instruments. A credit default swap (CDS) is the risk-transfer leg: the bank pays a premium to a counterparty, and if losses in the reference portfolio exceed an agreed threshold, the counterparty pays the bank. A credit-linked note (CLN) is the funding leg: investors buy notes, the cash they pay in gets held as collateral against exactly that CDS exposure, and their principal shrinks if losses actually hit. In the OceanFirst deal, 400CM structured a CDS against the mortgage portfolio for capital relief, then issued DBRS-rated CLNs referencing that CDS to institutional investors who wanted the yield.

The payoff for the bank is regulatory capital relief under Basel III/IV rules. Banks must hold capital against risk-weighted assets (RWAs), and mortgages carry a risk weight (currently a flat 50% for most performing first-lien loans under the standardized approach in the US, per Simpson Thacher's summary of the current framework). Transfer the credit risk on a slice of that book to a third party, and regulators let the bank reduce the RWAs against it. That frees capital to make new loans or return to shareholders, without diluting existing shareholders by issuing new equity. Christopher Maher, OceanFirst's CEO, called the trade "a cost-effective risk reduction and capital management transaction" in the same BusinessWire release.

This is not a niche tool anymore. According to the International Association of Credit Portfolio Managers' 2025 Global SRT Bank Survey, global SRT transaction volume rose 20% in 2025 to €30 billion, protecting credit risk on €378 billion of underlying loans. Roughly half of that issuance came from global systemically important banks (G-SIBs). The US accounts for an estimated 20% to 30% of global SRT activity, with roughly $170 billion in SRTs outstanding as of late 2024. Non-bank buyers dominate the investor base: PGGM, ArrowMark, AXA IM Alts, Pemberton, and Crescent Capital all show up repeatedly as counterparties across the market.

The OceanFirst Deal, Specifically

OceanFirst Financial Corp.'s bank subsidiary, OceanFirst Bank, N.A., is a $23 billion regional bank headquartered in New Jersey, serving customers from Massachusetts through Virginia. It is not a giant. That matters. Most SRT activity historically comes from large regional and global banks with dedicated capital markets desks. A $23 billion community-oriented bank doing a $1.5 billion SRT signals the tool is filtering down-market, a shift Holland & Knight's analysis of the 2026 capital proposals suggests regulators want to encourage, so mortgage lending stays inside the regulated banking system rather than migrating to nonbanks.

400 Capital Management is the counterparty and issuer. Founded in 2008, the New York-based firm manages roughly $7.5 billion for institutional clients across offices in New York and London, and specializes in asset-based credit strategies. This is a firm that trades credit for a living, not a bank looking for a side hustle.

The structure closed in two linked steps. First, 400CM entered a CDS referencing the $1.5 billion OceanFirst mortgage portfolio, transferring the credit risk on that book and delivering the regulatory capital relief. Second, 400CM issued CLNs rated by DBRS Morningstar that reference the CDS, and sold those notes to institutional investors seeking exposure to rated US residential mortgage credit. DBRS Morningstar publishes its rating criteria for these deals under its structured finance methodology catalog, and assigns ratings based on stress scenarios applied to the specific reference pool, not a generic mortgage benchmark. That rating is the piece that makes this different from a private bilateral CDS: an outside agency put its name on the credit risk, which is what lets institutional buyers who need rated paper, insurers and some pension allocators among them, actually participate.

400CM frames this as a first, and the framing checks out on the specific combination: fund-issued (not bank-arranged), rated (not privately negotiated with no external validation), and residential mortgage (not corporate or consumer credit, which dominate existing US SRT issuance). Willoughby's comment about building a "vibrant SRT ecosystem" is aspirational marketing language, and I would treat it as exactly that until a second and third deal close using the same template.

The CDO Echo Nobody Wants to Say Out Loud

Here is where I get direct. A structure where a bank transfers mortgage credit risk to a fund, which then repackages that risk into rated notes sold to institutional investors, resembles the collateralized debt obligation (CDO) machinery that amplified the 2008 financial crisis. I am not saying this deal is a CDO. The differences matter: 400CM retains the underlying credit risk directly rather than layering multiple tranches of pooled securitizations on top of each other, DBRS Morningstar is rating a single, transparent reference portfolio rather than a repackaged pool of other structured products, and post-2008 capital and disclosure rules constrain what banks can do here far more than they could in 2006. But the core mechanic, converting on-balance-sheet credit risk into tradable, rated paper held by parties several steps removed from the original borrower, is the same mechanic that failed when underwriting quality slipped and correlation assumptions proved wrong. Watch what happens to underwriting discipline as this market grows. That is the tell.

Second, access. This deal is not available to individual accredited investors through any public vehicle. The CLNs went to institutional investors: insurers, pension allocators, credit funds with the balance sheet and legal infrastructure to hold rated structured notes. If you are an accredited investor reading this hoping to buy a piece of the OceanFirst SRT, you cannot, not directly, and probably not through a retail-accessible fund anytime soon. Some interval funds and credit-focused BDCs (business development companies) have started dipping into SRT-adjacent strategies, but the primary market here remains closed to individuals. Treat any pitch that claims otherwise with real suspicion.

Third, regulatory scrutiny is coming, and it should. The Federal Reserve and the Office of the Comptroller of the Currency (OCC) already review SRT deals for whether they achieve genuine risk transfer or merely create the appearance of it for capital relief purposes. Regulators call this "significant risk transfer" for a reason: they have to certify the transfer is real before the bank gets to reduce its RWAs. If the risk transferred is too thin, or if the bank retains too much economic exposure through side agreements or first-loss retention, examiners can deny the capital relief after the fact, which leaves the bank holding both the cost of the trade and the original capital charge. As US SRT volume grows and more non-bank fund managers structure their own deals rather than banks arranging them, expect regulators to ask harder questions about correlation risk, counterparty concentration, and whether the rating agencies involved are stress-testing these portfolios as rigorously as they claim.

The pending Basel rewrite adds a fourth layer of uncertainty. If mortgage risk weights fall as proposed, from a flat 50% to a range as low as 20% to 25% for the best-collateralized loans, some banks that pursued SRTs purely for capital relief may find the trade less economically necessary. Fewer sellers competing for the same pool of institutional buyers changes pricing. Watch spreads on new mortgage SRT issuance over the next 12 months as a signal for whether banks still see the trade as worth the fee.

What You Should Actually Do

If you are an accredited investor drawn to this theme, do not chase the OceanFirst deal itself. It is closed, and it was never open to you. Instead, look at three concrete paths. First, ask your credit fund manager or advisor directly whether any of the multi-strategy credit funds you already hold have SRT or capital-relief-trade exposure buried in their asset-based credit sleeve; several multi-strategy managers, not just 400CM, run this book. Second, if you want direct exposure, research the small number of interval funds and private credit vehicles marketed to accredited investors that explicitly disclose SRT or capital-relief-note allocations in their prospectus, and read the concentration and liquidity terms closely before committing capital. Third, track the Basel III endgame comment period and final rule. The PwC analysis of the March 2026 proposal notes comments closed June 18, 2026, with no confirmed implementation timeline yet. Whatever the agencies finalize will shape how much demand banks still have for deals like this one over the next two to three years, and that demand curve is what will determine whether SRT-linked credit funds are a durable allocation or a trade that fades once mortgage risk weights drop.

Verify before you commit. Ask any manager pitching SRT exposure for the specific reference portfolio, the rating agency involved, the attachment and detachment points on the tranche you would hold, and what happens to your principal if losses breach those points. If they cannot answer with numbers this specific, that is your answer.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.